title: When will we know enough to treat atrial fibrillation?
authors.forename: Mark E
authors.initials: ME
authors.lastname: Anderson
mesh_terms: D000110:Acetylcholinesterase / Q000187:drug effects / Q000235:genetics*; D000483:Alleles; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000235:genetics*; D005838:Genotype; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D012084:Renin-Angiotensin System
chemical_list: D000889:Anti-Arrhythmia Agents; D000110:Acetylcholinesterase; C488034:ACE protein, human; D007703:Peptidyl-Dipeptidase A